The real-world dose-relativity of sevelamer hydrochloride and lanthanum carbonate monotherapy in patients with end-stage renal disease.
about
Sevelamer Carbonate and Lanthanum Usage Evaluation and Cost Considerations at a Veteran's Affairs Medical CenterLanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease.Iron parameters in patients with end-stage renal disease receiving lanthanum carbonate or other non-iron-based phosphate binders: Results from a phase 3, randomized open-label study
P2860
The real-world dose-relativity of sevelamer hydrochloride and lanthanum carbonate monotherapy in patients with end-stage renal disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
The real-world dose-relativity ...... with end-stage renal disease.
@ast
The real-world dose-relativity ...... with end-stage renal disease.
@en
type
label
The real-world dose-relativity ...... with end-stage renal disease.
@ast
The real-world dose-relativity ...... with end-stage renal disease.
@en
prefLabel
The real-world dose-relativity ...... with end-stage renal disease.
@ast
The real-world dose-relativity ...... with end-stage renal disease.
@en
P2093
P2860
P1433
P1476
The real-world dose-relativity ...... with end-stage renal disease.
@en
P2093
J Brian Copley
Michael S Keith
Peter Preston
Rosamund J Wilson
P2860
P2888
P304
P356
10.1007/S12325-013-0077-5
P407
P577
2013-12-05T00:00:00Z